Success Stories: A Postdoctoral Fellow from India Working in Cancer Biology Gets EB1-A Approval with Our Help, Premium Processing Requested
Client’s Testimonial:
“Thank you for all the efforts and for working together for my EB1A approval.”
On August 30th, 2021, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Fellow in the Field of Cancer Biology (Approval Notice).
General Field: Cancer Biology
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: India
State of Residence at the Time of Filing: Maryland
Approval Notice Date: August 30th, 2021
Processing Time: 4 months, 25 days (Premium Processing Requested)
Case Summary:
Our client for an EB1-A (Alien of Extraordinary Ability) petition from India with a Ph.D. in life sciences, is one of the few leading chemo-resistant multiple myeloma experts in cancer biology, and she has achieved a consistent and notable record of success and influence in this area of study. She is especially well-known for her research that uncovered the mechanistic basis of recognition in the MYC G-quadruplex in cancer cells through chemical and structural studies. She has spent years investigating issues related to chemo-resistant multiple myeloma and is regarded as an authority in the field. The field has recognized her authority by inviting her to review and evaluate the work of her peers no fewer than 100 times. In addition to her work as a peer reviewer, she serves as an associate editor on the editorial board of several international journals of repute in her field.
Her work has resulted in 13 peer-reviewed scientific articles and 1 book chapter. Moreover, her papers have been published in some of the most discerning, high-impact journals in her field. Not only has she successfully completed and published the results of her research in the field, but her discoveries have also gone on to influence her peers. That is, these publications have been cited by researchers in at least 35 countries according to Google Scholar. Due to its great applicability in the field, her research in cancer biology has been cited 262 times in other peer-reviewed journal articles according to Google Scholar.
Furthermore, her research has been supported by funding from the National Institutes of Health. The National Institutes of Health funds projects that promote innovative scientific solutions to public health problems. This support of her research therefore serves as evidence that her research holds practical relevance to public health in the United States and beyond. This is why her recommenders had the following to say of her work:
“Her groundbreaking research in this area has provided key insights into the development of novel therapies and probes of gene expression. These findings are crucial for discovering new therapeutics for challenging disease areas, including cancer disease, which is responsible for over 9.5 million deaths worldwide each year. As these figures indicate, it is vital that [she] continue to provide the research community with innovative and effective strategies for combating this life-threatening disease.”
“Her research is especially vital for public health in the U.S., given that the American Cancer Society estimates that approximately 21,750 of U.S. women will receive a new diagnosis of ovarian cancer in the year 2020, and about 13,940 women will die from the disease. As [her] work has led to major advances in cancer therapeutics, her research is clearly a boon for public health and the U.S. economy.”
These academic and professional records aided by the letters of recommendation were put together by our team of experts in the form of her petition letter. We are proud of the work our dedicated team did and our client tells us the same.